2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
CNS
3
Conditions
Glioblastoma
3
Brain Edema
1
Interventions
Temozolomide
623
Radiotherapy
410
Bevacizumab
256
Magnetic Resonance Spectroscopy
226
Cyclophosphamide
179
Radiosurgery
162
Carboplatin
160
Etoposide
132
Radiation
128
Vincristine
115
Irinotecan
115
Cisplatin
103
Filgrastim
100
Specimen Handling
90
Nivolumab
88
pembrolizumab
83
Surgical Procedures, Operative
83
Lomustine
82
Topotecan
73
Doxorubicin
61
Melphalan
59
Carmustine
57
Radiotherapy, Intensity-Modulated
56
sargramostim
53
Isotretinoin
53
Peripheral Blood Stem Cell Transplantation
52
Granulocyte Colony-Stimulating Factor
51
Chemotherapy, Adjuvant
51
Blood Specimen Collection
51
Erlotinib Hydrochloride
50
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
antisecretory factor
×
CNS
×
Clear all
NCT07364786
2026-01-23
AFGBMBiop
Skane University Hospital
Phase 2
Recruiting
10 enrolled
NCT05669820
2026-01-09
AFGB2
Skane University Hospital
Phase 2/3
Recruiting
300 enrolled
NCT04116138
2021-04-28
AFGBM1
Skane University Hospital
Phase 1/2
Completed
8 enrolled